Skip to content
healthcare.dev

Methotrexate

NDC 51079-670, methotrexate, tablet, from Mylan Institutional Inc..

Product NDC
51079-670
Status
Listed
Labeler
Mylan Institutional Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA081235
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51079-670 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHOTREXATE SODIUM2.5 mg/1

Pharmacologic classes

Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]

Package NDCNDC-11Package
51079-670-055107906700520 BLISTER PACK in 1 CARTON (51079-670-05) / 1 TABLET in 1 BLISTER PACK (51079-670-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8df0780e-0fbd-4ab8-80b0-7a5eaa08ec0a
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=51079-670
  • NADAC price for package 51079067005

    GET /v1/drugs/nadac/51079067005

Use it

Look up 51079-670 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51079-670 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51079-670. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.